CVS
32
3
SYK
55
-2
PLD
45
5
MET
60
2
GILD
58
2
YUM
45
2
VZ
30
5
K
56
3
BIIB
42
2
NRG
37
-2
ROST
66
4
MPC
33
2
ZION
56
4
AAP
32
2
ROP
50
2
PYPL
52
2
AAPL
65
-2
EOG
30
-2
EW
57
2
SRE
45
-2
CVS
32
3
SYK
55
-2
PLD
45
5
MET
60
2
GILD
58
2
YUM
45
2
VZ
30
5
K
56
3
BIIB
42
2
NRG
37
-2
ROST
66
4
MPC
33
2
ZION
56
4
AAP
32
2
ROP
50
2
PYPL
52
2
AAPL
65
-2
EOG
30
-2
EW
57
2
SRE
45
-2
Financhill
Back

Novartis AG 10K Form

Sell
50

NVS
Novartis AG

Last Price:
$98.11
Seasonality Move:
-2.4%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NVS News And Ratings

See the #1 stock for the next 7 days that we like better than NVS

NVS Financial Statistics

Sales & Book Value

Annual Sales: $46.7B
Cash Flow: $5.5B
Price / Cash Flow: 16.13
Annual Sales: $21.67
Price / Book: 4.54

Profitability

EPS (TTM): 8.53000
Net Income (TTM): $17.6B
Gross Margin: $34.2B
Return on Equity: 41.89%
Return on Assets: 17.33%

Novartis AG Earnings Forecast

Key Novartis AG Financial Ratios

  • The Gross Profit Margin over the past 26 years for NVS is 73.27%.
  • The Selling, General & Administrative Expenses for NVS have been equal to 26.83% of Gross Profit Margin.
  • The Research & Development expenses have been 24.37% of Revenue.
  • The Interest Expense is 5.76% of Operating Income.
  • The Net Earning history of NVS is 31.83% of Total Revenues.
  • Per Share Earnings over the last 26 years have been positive in 17 years.

Novartis AG Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: NVS
CUSIP: 66987V
Website: novartis.com

Debt

Debt-to-Equity Ratio: 0.7
Current Ratio: 1.11
Quick Ratio: 0.79

Price-to-Earnings

Trailing P/E Ratio: 13.86
Forward P/E Ratio: 11.82

NVS Technical Analysis vs Fundamental Analysis

Sell
50
Novartis AG (NVS) is a Sell

Is Novartis AG a Buy or a Sell?

  • Novartis AG stock is rated a Sell
    The current Novartis AG [NVS] share price is $98.40. The Score for NVS is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.